AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Agena Bioscience at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Agena Bioscience brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 629. Its program centres on pharmacogenomics implementation, with sessions on applying CPIC guidelines to NAT2 using CDC reference materials and on moving DPYD testing from guideline into routine practice.

OrganizationAMP 2026 Attendance
Agena Bioscience
San Diego, CA
Suppliers
MassARRAY platform for targeted genomic analysis — mutation profiling, liquid biopsy and pharmacogenetics for research laboratories.
Booth
Exhibiting at Booth 629
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
11:00am–11:50am
NAT2 Pharmacogenomics: Applying CPIC Guidelines with CDC GeT-RM Reference Materials
NAT2 acetylator genotyping: applying dosing guidelines and using CDC reference materials to validate the assay.
Workshop
Wed, Nov 11
12:00pm–12:50pm
DPYD - From Guidelines to Implementation
Testing DPYD variants before fluoropyrimidine chemotherapy: which variants to include, translating results to dose, and adoption barriers.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Agena Bioscience

Tell us what you sell and we’ll find the people at Agena Bioscience most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction